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1. Defining animal models
 The use of animals as experimental models for human diseases is currently seen as an imper-
ative in understanding the causes, biology, and prevention of diseases. Animal models over 
the years have been used extensively in biomedical field since the early 1980s [1]. Current 
understanding of these models tends to be a specific combination of an animal species, cell, 
tissue, organ, gene, or a challenge agent, and its directed route of exposure to produce and/or 
mimic a disease process or pathological condition in multiple important aspects approximat-
ing or corresponding to the human disease scenario or condition of interest. An important fact 
is that the models have to be reproducible.
It is obvious that laboratory animals play a crucial role in scientific research, discovery, and 
technological advances and in a substantive manner improve the lives of people and other 
useful animals. It may suffice to say that animals are used as models to study human biol-
ogy and diseases and as test subjects for the development and testing of drugs, vaccines, and 
other biologicals (i.e., antibodies, hormones, etc.) to enhance and promote human health. This 
book, therefore, was written for medical practitioners, drug/therapeutic agent developers, 
biomedical scientists/bioengineers research students, bioethicists, behavioral scientists, and 
the general public who aspire to enrich their understanding of human diseases and develop-
ment of effective therapeutics using animal models as clearly defined herein. Over the last 
century, almost all medical knowledge, treatment regimes, and medical device development 
have involved research using animals. Disease experimentation using animal models may be 
a  deliberate design or  an inevitable  choice which possible due to the common descent of all 
organisms which even in the face of evolution many of them conserve their metabolic, devel-
opmental, and genetic material.
© 2018 The Author(s). Licensee IntechOpen. This chapter is distributed under the t rms of the Crea ive
Comm ns Attribution Lic nse (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
2. Trendy outlook
Animals were used to study human physiology and anatomy in the second century AD as 
documented by a Greek physician and philosopher, Galen, using mainly apes and pigs [2]. 
Galen applied his findings directly to humans without considering taxonomic relatedness. It 
was until the late sixteenth century that this error began to be recognized. Previously in 1865, 
a French physiologist by name Claude Bernard published the first book, An Introduction to the 
Study of Experimental Medicine [3], advocating the use of chemical and physical induction of 
disease in animals for biomedical research. Around that same time, Louis Pasteur in France 
and Robert Koch in Germany introduced the concept of specificity into medicine and the 
“germ theory of disease.”
It is noted that from 1901, two-thirds of the Nobel Prizes in medicine have relied majorly 
on animal models for their research, more recently seven (7) of the last ten (10) were animal 
model-based breakthroughs (Table 1) [4]. Researchers now rely heavily on development of 
animal models to explore all areas of medical science specifically in the assessment of patho-
genic mechanisms, diagnostic and therapeutic procedures, vaccine development, nutrition, 
metabolic diseases, and the efficacy of novel drug development as captured in this book.
A typical instance in the trending use of animals as disease model is the transition from nonhu-
man primates such as chimpanzee to mouse/rat models in diabetic retinopathy (Chapter 2/3) 
and in HIV research (chapter 9) [5]. Larger animals are deemed relatively closest to humans (e.g., 
chimpanzee). However, these animals have become increasingly difficult to maintain and to 
handle; besides their costly nature. A more disturbing fact is that most human diseases could not 
be replicated in them, and the causative human agent hardly infects these nonhuman primates 
as well as difficulty in development of human symptoms and therapeutic responses. Scientists, 
therefore, resulted to started developing simpler and effective models most especially transgenic 
(humanized) mouse models [6] that mimic human responses to study and understand various 
aspects of infectious agents, pathogenesis, disease progression, nature of protective immunity 
and vaccine development. An ideal animal model for human disease research should possess 
certain characteristics as a prerequisite for a standard model. The chapters presented in this 
book elucidate the following notable characteristics of a chosen animal model:
(i) A close relative or closely associated with the host tissue distribution, disease progres-
sion, and similar route of infection, if not identical.
(ii) Disease course should be relatively shorter in the animal model, to allow for comple-
tion of the efficacy test in reasonable time, permitting rapid transition to human clinical 
testing.
(iii) Despite the differences in genetic makeup of humans and animals, there should be suf-
ficient disease correlation and pathological equivalence.
(iv) The model should be easy to maintain, work with, easily available in adequate number, 
relatively inexpensive, and free of regulatory constraints.
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Year Nobel Laureate Animal model Contribution to modern medicine
2015 William C. Campbell 
and Satoshi Ōmura and 
Youyou Tu
Mice, dogs, sheep, 
cattle, chickens, 
monkeys
Campell and Omura for discoveries concerning a novel 
therapy against infections caused by roundworm 
parasites and Youyou Tu for her discoveries concerning 
a novel therapy against malaria
2014 John O’Keefe and 
May-Britt and Edvard 
I. Moser
Rats Discoveries of cells that constitute a positioning system 
in the brain (an inner GPS)
2013 James E. Rothman Hamsters Discoveries of machinery regulating vesicle traffic, a 
major transport system in our cells
2013 Thomas C. Südhof Mice Discoveries of machinery regulating vesicle traffic, a 
major transport system in our cells
2012 Sir John B. Gurdon Frogs, mice For the discovery that mature cells can be 
reprogrammed to become pluripotent
2012 Shinya Yamanaka Frogs, mice For the discovery that mature cells can be 
reprogrammed to become pluripotent
2011 Bruce A. Beutler Mice Discoveries concerning the activation of innate 
immunity
2011 Jules A. Hoffmann Flies Discoveries concerning the activation of innate 
immunity
2011 Ralph M. Steinman Mice For his discovery of the dendritic cell and its role in 
adaptive immunity
2010 Robert G. Edwards Rabbits The development of in vitro fertilization
2009 Carol W. Greider Protozoan, mouse, frog Discovery of how chromosomes are protected by 
telomeres and the enzyme telomerase
2009 Elizabeth H. Blackburn Protozoan, mouse Discovery of how chromosomes are protected by 
telomeres and the enzyme telomerase
2009 Jack W. Szostak Protozoan Discovery of how chromosomes are protected by 
telomeres and the enzyme telomerase
2008 Harald zur Hausen Hamster, mouse, cow Discovery of human papilloma viruses causing cervical 
cancer
2008 Françoise 
Barré-Sinoussi
Monkey, chimpanzee, 
mouse
Discovery of human immunodeficiency virus
2008 Luc Montagnier Monkey, chimpanzee, 
mouse
Discovery of human immunodeficiency virus
2007 Mario R. Capecchi Mouse Discoveries of principles for introducing specific gene 
modifications in mice by the use of embryonic stem 
cells
2007 Sir Martin J. Evans Mouse, chick Discoveries of principles for introducing specific gene 
modifications in mice by the use of embryonic stem 
cells
2007 Oliver Smithies Mouse Discoveries of principles for introducing specific gene 
modifications in mice by the use of embryonic stem 
cells
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3. Expert view vs. common sense
Many scientific articles and books written in recent times have attempted to bridge the gap 
between effective animal model and the equivalent human pathological replication. It may 
seem controvertible on the acceptance of animal models as equivalent to human testing. As 
this may not apply in all cases, however, there are notifiable instances where animal mod-
els may substantially suffix. This is exemplified by the US FDA Animal Efficacy Rule (also 
known as Animal Rule) which applies to development and testing of drugs and biologicals in 
animal models to reduce or prevent serious/life-threatening conditions caused by exposure 
to lethal or permanently disabling toxic agents (chemical, biological, radiological, or nuclear 
substances) and in instances where human efficacy trials are not feasible or ethical [7].
In this book, animal models of global disease of interest were extensively discussed. The seven-
teen (17) chapters presented by experienced experts in the field detailed the practical and theo-
ritical steps in animal model development and various approaches to achieve and/or develop 
specific models X-raying their limitations, interspecies variations, and comparison of differ-
ent models (chemically induced, biological, xenograft, syngeneic, and genetically modified) 
which best suited for good experimental results. The book is designed to assist researchers 
make a beneficial choice of experimental animal relevant to their research design, hypothesis, 
and expected results. The chapters as much as intriguing presents scientific bases for choice of 
experimental animals on notable and widely researched global disease of interest ranging from 
central diabetes insipidus, diabetic retinopathy, hair research and regeneration, skeletal remod-
eling, ductular reaction in chronic human liver diseases, induced oxidative stress, inflamma-
tory bowel diseases, and double incontinence HIV/AIDS to neuroinflammatory disease.
One of the factors impeding the translation of knowledge from preclinical to clinical studies 
has been the limitations of in vivo disease models in which specific animal models discussed 
Year Nobel Laureate Animal model Contribution to modern medicine
2006 Andrew Z. Fire Nematode roundworm Discovery of RNA interference—gene silencing by 
double-stranded RNA
2006 Craig C. Mello Nematode roundworm Discovery of RNA interference—gene silencing by 
double-stranded RNA
2005 Barry J. Marshall Piglet Discovery of the bacterium Helicobacter pylori and its 
role in gastritis and peptic ulcer disease
2004 Richard Axel Mouse, Drosophila (fruit 
flies)
Discoveries of odorant receptors and the organization 
of the olfactory system
2004 Linda B. Buck Mouse Discoveries of odorant receptors and the organization 
of the olfactory system”
2003 Paul C. Lauterbur Clam, mouse, dog, rat, 
chimpanzee, pig, rabbit, 
frog
Discoveries concerning magnetic resonance imaging 
(MRI)
Table 1. Contributions of lab animals to biomedical research (adapted from Foundation for Biomedical Research [4]).
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in the chapters tend to address. Regulatory authorities, however, require vaccine candidates to 
undergo preclinical evaluation in animal models before they enter the clinical trials in humans 
[8]. The overarching goal of a new vaccine is to stimulate the immune system to elicit an effec-
tive response against the pathogen it is being designed for; currently, experts have noted that 
no alternatives to the use of live animals exist for evaluation of the vaccine response despite 
advances in computational sciences for the search of an in silico model. One of the issues bor-
dering scientific expediency in the development and use of animal models is on bioethics and 
animal rights. Thus, qualification and ethical consideration need appropriate clarification.
4. Need for standardization of model
There is a need to qualify and/or standardize animal models. Qualification of an animal 
model implies that a specific animal species given a specific challenge agent by a specific 
route produces a disease process or condition that in multiple important aspects corresponds 
to the human disease or condition of interest [9]. The experts’ discussion (chapters) pres-
ents the need for standardization or qualification of models. The question of whether or not 
there should be a standardized or qualified model is the basis of one of the main current con-
troversies in developing animal models for human diseases. Having a standardized animal 
model relates to the appropriate research use and may be regarded as a complete and precise 
description of intended use and application of the qualified animal model in drug develop-
ment and regulatory processes. The process must specify the details necessary to replicate the 
model. Other criteria may be summarized as follows:
(a) Known and identified animal thus proposed for use
(b) Known and characterized challenge agent
(c) Procedural information for the challenge agent exposure
(d) Identification of the primary and secondary endpoints
(e) Potential triggers for intervention
5. Next-generation models
An interesting aspect of the book is the respective discussion in each chapter of next-gen-
eration models and how perceived limitations of current animal models could be obviated. 
Recent animal model research has focused on the (i) refinement of existing models and the 
development of new ones, (ii) use of these models to research key questions about the disease 
pathology, and (iii) key findings with these models testing therapeutic and vaccine concepts 
[10]. Margaret Hamburg wrote “We must bring 21st century approaches to 21st century prod-
ucts and problems” [11]. This scientific era entails rapid and unprecedented development of 
enabling biotechnologies with great promise for the future.
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6. What this book argues
As implied above, the concept of animal models dealt with in this book discusses appropriate 
mechanistic models for selected prevalent human diseases. An animal model is imperative 
for preclinical trials, disease pathway and pathological elucidation, new drug development, 
and vaccine construction. Against any odd, the use of animals especially rat and mouse 
seems indispensable in today’s scientific world. The book presents reproducible experi-
mental approach using animal models for human diseases with measurable equivalence to 
that of humans. It also presents models of high human predictive value. Despite the current 
insights and promising technologies, no scientific method can at this time fully address the 
limitation(s) of using animal models as complete surrogates for humans.
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